{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:40:26Z","timestamp":1788349226224,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To assess population-level trends, characteristics, and outcomes of high-grade serous tubo-ovarian carcinoma in the United States.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This retrospective cohort study queried the National Cancer Institute's Surveillance, Epidemiology, and End Results Program. The study population was 27,811 patients diagnosed with high-grade serous tubo-ovarian carcinoma from 2004 to 2020. The exposure was the primary cancer site (ovary or fallopian tube). Main outcome measures were temporal trends, clinical characteristics, and overall survival associated with primary cancer site assessed in multivariable analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>The study population comprised 23,967 diagnoses of high-grade serous ovarian carcinoma and 3,844 diagnoses of high-grade serous fallopian tubal carcinoma. The proportion of diagnoses of high-grade serous fallopian tubal carcinoma increased from 365 of 7,305 (5.0%) in 2004\u20132008 to 1,742 of 6,663 (26.1%) in 2017\u20132020. This increase was independent in a multivariable analysis (adjusted odds ratio [aOR] vs 2004\u20132008, 2.28 [95% CI, 1.98\u20132.62], 3.27 [95% CI, 2.86\u20133.74], and 6.65 [95% CI, 5.84\u20137.57] for 2009\u20132012, 2013\u20132016, and 2017\u20132020, respectively). This increase in high-grade serous fallopian tubal carcinoma was seen across age groups (4.3\u20135.8% to 22.7\u201328.3%) and across racial and ethnic groups (4.1\u20136.0% to 21.9\u201327.5%) (all <jats:italic toggle=\"yes\">P<\/jats:italic> for trend &lt;.001). Among the cases of tumors smaller than 1.5 cm, the increase was particularly high (16.9\u201367.6%, <jats:italic toggle=\"yes\">P<\/jats:italic> for trend &lt;.001). Primary-site tumors in the high-grade serous fallopian tubal carcinoma group were more likely to be smaller than 1.5 cm (aOR 8.26, 95% CI, 7.35\u20139.28) and unilateral (aOR 7.22, 95% CI, 6.54\u20137.96) compared with those in high-grade serous ovarian carcinoma. At the cohort level, the diagnosis shift to high-grade serous fallopian tubal carcinoma was associated with narrowing differences in survival over time between the two malignancy groups: adjusted hazard ratio 0.84 (95% CI, 0.74\u20130.96), 0.91 (95% CI, 0.82\u20131.01), 1.01 (95% CI, 0.92\u20131.12), and 1.12 (95% CI, 0.98\u20131.29) for 2004\u20132008, 2009\u20132012, 2013\u20132016, and 2017\u20132020, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>This population-based assessment suggests that diagnoses of high-grade serous tubo-ovarian carcinoma in the United States have been rapidly shifting from high-grade serous ovarian to fallopian tubal carcinoma in recent years, particularly in cases of smaller, unilateral tumors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000005562","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T21:02:46Z","timestamp":1711054966000},"page":"660-669","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma"],"prefix":"10.1097","volume":"143","author":[{"given":"Matthew W.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alodia M.","family":"Girma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/14737140.2016.1247699","article-title":"Serous tubal intraepithelial carcinoma (STIC): clinical impact and management","volume":"16","author":"Weinberger","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004347-200304000-00001","article-title":"Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations","volume":"22","author":"Colgan","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ygyno.2018.11.033","article-title":"The fallopian tube, \u201cprecursor escape\u201d and narrowing the knowledge gap to the origins of high-grade serous carcinoma","volume":"152","author":"Soong","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PGP.0000000000000336","article-title":"The fallopian tube origin and primary site assignment in extrauterine high-grade serous carcinoma: findings of a survey of pathologists and clinicians","volume":"36","author":"McCluggage","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ygyno.2018.01.030","article-title":"Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US","volume":"149","author":"Liao","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2019.11.122","article-title":"Evolving population-based statistics for rare epithelial ovarian cancers","volume":"157","author":"Matsuo","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ygyno.2020.10.027","article-title":"Possible candidate population for neoadjuvant chemotherapy in women with advanced ovarian cancer","volume":"160","author":"Matsuo","year":"2021","journal-title":"Gynecol Oncol"},{"key":"R19-20250423","first-page":"440","article-title":"The changing landscape of gynecologic cancer mortality in the United States","volume":"139","author":"Giaquinto","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"R24-20250423","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/PGP.0000000000000908","article-title":"Data set for the reporting of ovarian, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"41","author":"Gilks","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"399.e1","DOI":"10.1016\/j.ajog.2021.06.074","article-title":"Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States","volume":"225","author":"Mandelbaum","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"721.e1","DOI":"10.1016\/j.ajog.2020.04.028","article-title":"The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States","volume":"223","author":"Mandelbaum","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/PGP.0000000000000429","article-title":"Disease distribution in low-stage tubo-ovarian high-grade serous carcinoma (HGSC): implications for assigning primary site and FIGO stage","volume":"37","author":"Singh","year":"2018","journal-title":"Int J Gynecol Pathol"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fonc.2016.00108","article-title":"Ovarian cancer: the fallopian tube as the site of origin and opportunities for prevention","volume":"6","author":"George","year":"2016","journal-title":"Front Oncol"},{"key":"R29-20250423","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/ijgc-2022-003468","article-title":"Retrospective study of histopathological and prognostic characteristics of primary fallopian tube carcinomas: twenty-year experience (SOCRATE)","volume":"32","author":"Borghese","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N Engl J Med"},{"key":"R31-20250423","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa1105535","article-title":"Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer","volume":"366","author":"Ledermann","year":"2012","journal-title":"N Engl J Med"},{"key":"R32-20250423","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R34-20250423","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamasurg.2023.4164","article-title":"Salpingectomy for the primary prevention of ovarian cancer: a systematic review","volume":"158","author":"Kahn","year":"2023","journal-title":"JAMA Surg"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T17:02:44Z","timestamp":1745427764000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005562","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"2023-11-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}